95 related articles for article (PubMed ID: 7935979)
1. Myeloid activation antigen CD66/67: immunochemical and immunocytometric characterization with the Vth workshop monoclonal antibodies.
Hunáková L; Duraj J; Holománová D; Sedlák J; Chorváth B
Neoplasma; 1994; 41(3):129-35. PubMed ID: 7935979
[TBL] [Abstract][Full Text] [Related]
2. Expression and alterations of CD66 antigen by interferon-gamma in human breast carcinoma cell lines.
Sedlak J; Duraj J; Hunakova L; Chorvath B
Anticancer Res; 1994; 14(6B):2473-6. PubMed ID: 7872669
[TBL] [Abstract][Full Text] [Related]
3. Isoforms of leukocyte common antigen (CD45) on human neoplastic hematopoietic cell lines.
Sedlák J; Duraj J; Festin R; Plesková I; Poláková K; Chorváth B
Neoplasma; 1989; 36(6):643-50. PubMed ID: 2533326
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies (series Bra-) of broad (non-lineage) or restricted (myelomonocytic) reactivities elicited with granulocytes or K 562 cells.
Chorváth B; Sedlák J; Suliková M; Plesková I; Augustínová M; Duraj J
Neoplasma; 1989; 36(6):633-42. PubMed ID: 2615868
[TBL] [Abstract][Full Text] [Related]
6. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.
Bonde J; Meyer K; Broe MK; Hokland M; Turley H; Hokland P
Br J Haematol; 1996 Feb; 92(2):269-79. PubMed ID: 8602985
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family.
Stoffel A; Neumaier M; Gaida FJ; Fenger U; Drzeniek Z; Haubeck HD; Wagener C
J Immunol; 1993 Jun; 150(11):4978-84. PubMed ID: 8496599
[TBL] [Abstract][Full Text] [Related]
8. CD66 monoclonal antibodies recognize a phosphotyrosine-containing protein bearing a carcinoembryonic antigen cross-reacting antigen on the surface of human neutrophils.
Skubitz KM; Ducker TP; Goueli SA
J Immunol; 1992 Feb; 148(3):852-60. PubMed ID: 1370520
[TBL] [Abstract][Full Text] [Related]
9. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
10. Modulation of protectin (CD59 antigen) cell surface expression on human neoplastic cell lines.
Sedlák J; Hunáková L; Duraj J; Grófová M; Chorváth B
Neoplasma; 1993; 40(6):337-40. PubMed ID: 7507222
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CALLA (CD10) antigen on cultured ALL (REH) cells: effect of various modulators.
Chorváth B; Sedlák J; Duraj J; Plesková I; Dubovský P; Augustinová M; Doxiadis I; Grosse-Wilde H
Neoplasma; 1990; 37(6):609-18. PubMed ID: 2148811
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
13. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
Koníková E; Kusenda J; Babusíková O; Glasová M
Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
[TBL] [Abstract][Full Text] [Related]
14. Sialylated Lewis(x) and Lewis(a) determinants expression on human neoplastic cell lines: immunocytometric study with the 5th workshop monoclonal antibodies.
Sedlák J; Hunáková L; Sulíková M; Chorváth B
Neoplasma; 1995; 42(2):49-52. PubMed ID: 7542364
[TBL] [Abstract][Full Text] [Related]
15. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional characterization of MCS-2 antigen (CD13) on myeloid leukemic cells and polymorphonuclear leukocytes.
Sakai K; Hattori T; Sagawa K; Yokoyama M; Takatsuki K
Cancer Res; 1987 Nov; 47(21):5572-6. PubMed ID: 3478135
[TBL] [Abstract][Full Text] [Related]
17. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.
Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K
J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67.
Bordessoule D; Jones M; Gatter KC; Mason DY
Br J Haematol; 1993 Mar; 83(3):370-83. PubMed ID: 7683483
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation.
Kuijpers TW; van der Schoot CE; Hoogerwerf M; Roos D
J Immunol; 1993 Nov; 151(9):4934-40. PubMed ID: 8104998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
